Fundraising FoxAsclepius Life Sciences Fund, LP
Venture capitalNew York · Seed–Series B · 3 people tracked
Find your way into Asclepius Life Sciences Fund, LP
Sign up to see every warm intro you have to Asclepius Life Sciences Fund, LP
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Asclepius Life Sciences Fund, LP team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
Asclepius Life Sciences Fund invests exclusively in private-market life sciences companies, spanning healthcare, pharmaceuticals, agriculture, personal care, biosciences, and biotechnology. The fund aims to capitalize on market inefficiencies in the sector by combining operational expertise, deep scientific insight, and rigorous financial analysis, supported by a leadership team with extensive experience in investment, biopharmaceuticals, life sciences, and healthcare management.
Source: firm website, verified Oct 26, 2026.
Team · 3 people
from the firm's website & public directoriesCo-Founder and Managing Principal of Asclepius Life Sciences Fund with 30+ years in biopharmaceuticals and life sciences, including over 25 transactions totaling more than $10 billion. He is Co-founder, President and CEO of ZyVersa Therapeutics and previously co-founded Coherus BioSciences, with earlier leadership roles at Insmed, Andrx, Roche, Amgen and IMS Health.
Co-Founder and Principal focused on biopharma and medical technology, holding Series 7 and Series 65 licenses. A physician (M.D., Columbia) with multiple business and public health degrees, he has held executive roles at Columbia/HCA, Crawford & Company and Premier, and works in telemedicine and connected health.
Managing Director of Asclepius Master Fund, LTD., representing the fund globally. A financial services executive with 30+ years of experience, he is CEO and Founder of MLG Capital in The Bahamas and previously held senior private banking roles at RBC, EFG International and Credit Suisse.
Frequently asked questions
- What stage does Asclepius Life Sciences Fund, LP invest at?
- Asclepius Life Sciences Fund, LP invests at the Seed, Series A, Series B stages.
- What sectors does Asclepius Life Sciences Fund, LP focus on?
- Asclepius Life Sciences Fund, LP focuses on AgTech, Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Asclepius Life Sciences Fund, LP located?
- Asclepius Life Sciences Fund, LP is headquartered in New York, US.
Images
Similar investors
Khosla Ventures is a venture capital firm that backs bold, early-stage, technology-driven companies across deep tech and other sectors, providing hands-on 'venture assistance' to help founders build category-defining businesses.
Novo Holdings is the investment arm of the Novo Nordisk Foundation and a leading life science investor that also manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity assets.
Snatched Ventures is a San Francisco-based early-stage venture capital firm backing DeepTech startups focused on sustainable innovation and operational transformation. It is led by a two-GP team combining corporate development and institutional investment management experience.
Xeraya Capital is a Malaysia-based life sciences venture capital and private equity firm that invests globally in life sciences while aiming to drive value locally.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.